LivingGLP1
Condition P14B

Tobacco use

People who smoke or use other tobacco products.

2 randomized trials; 0 fitted analyses across 7 outcomes.

All outcomes

Each outcome is analyzed per time window and estimand, with doses kept apart (each dose) and pooled (each medicine). Analyses with too few connected trials are shown as descriptive.

Serious adverse events

O25
Time windowEstimandTreatmentsTrialsNodesAnalysis
longest follow-upRecorded harmsDoses of a drug pooled12Descriptive only
longest follow-upRecorded harmsEach dose separately12Descriptive only

Discontinuation due to adverse events

O26
Time windowEstimandTreatmentsTrialsNodesAnalysis
longest follow-upRecorded harmsEach dose separately12Descriptive only
longest follow-upRecorded harmsDoses of a drug pooled12Descriptive only

Nausea

O27A
Time windowEstimandTreatmentsTrialsNodesAnalysis
longest follow-upRecorded harmsDoses of a drug pooled12Descriptive only
longest follow-upRecorded harmsEach dose separately12Descriptive only

Vomiting

O27B
Time windowEstimandTreatmentsTrialsNodesAnalysis
longest follow-upRecorded harmsEach dose separately12Descriptive only
longest follow-upRecorded harmsDoses of a drug pooled12Descriptive only

Diarrhea

O27C
Time windowEstimandTreatmentsTrialsNodesAnalysis
longest follow-upRecorded harmsDoses of a drug pooled12Descriptive only
longest follow-upRecorded harmsEach dose separately12Descriptive only

Constipation

O27D
Time windowEstimandTreatmentsTrialsNodesAnalysis
longest follow-upRecorded harmsEach dose separately12Descriptive only
longest follow-upRecorded harmsDoses of a drug pooled12Descriptive only

Discontinuation due to gastrointestinal adverse events

O27E
Time windowEstimandTreatmentsTrialsNodesAnalysis
longest follow-upRecorded harmsEach dose separately12Descriptive only
longest follow-upRecorded harmsDoses of a drug pooled12Descriptive only